Gentian Diagnostics ASA (FRA:6FK)

Gentian Diagnostics ASA Statistics

Total Valuation

FRA:6FK has a market cap or net worth of EUR 71.53 million. The enterprise value is 64.33 million.

Market Cap	71.53M
Enterprise Value	64.33M

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	15.42M
Shares Outstanding	n/a
Shares Change (YoY)	-1.29%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	16.02%
Float	11.69M

Valuation Ratios

The trailing PE ratio is 19.59 and the forward PE ratio is 52.63.

PE Ratio	19.59
Forward PE	52.63
PS Ratio	4.86
PB Ratio	4.15
P/TBV Ratio	4.94
P/FCF Ratio	71.45
P/OCF Ratio	67.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.29, with an EV/FCF ratio of 64.26.

EV / Earnings	17.62
EV / Sales	4.39
EV / EBITDA	25.29
EV / EBIT	32.66
EV / FCF	64.26

Financial Position

The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.01.

Current Ratio	5.98
Quick Ratio	4.16
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.16
Interest Coverage	7.55

Financial Efficiency

Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 7.79%.

Return on Equity (ROE)	23.54%
Return on Assets (ROA)	6.87%
Return on Invested Capital (ROIC)	7.79%
Return on Capital Employed (ROCE)	11.37%
Revenue Per Employee	233,671
Profits Per Employee	57,942
Employee Count	63
Asset Turnover	0.82
Inventory Turnover	1.63

Taxes

Income Tax	-1.62M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.60%
50-Day Moving Average	4.62
200-Day Moving Average	4.58
Relative Strength Index (RSI)	46.30
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:6FK had revenue of EUR 14.72 million and earned 3.65 million in profits. Earnings per share was 0.23.

Revenue	14.72M
Gross Profit	8.11M
Operating Income	1.98M
Pretax Income	2.03M
Net Income	3.65M
EBITDA	2.23M
EBIT	1.98M
Earnings Per Share (EPS)	0.23

Balance Sheet

The company has 7.39 million in cash and 163,155 in debt, giving a net cash position of 7.23 million.

Cash & Cash Equivalents	7.39M
Total Debt	163,155
Net Cash	7.23M
Net Cash Per Share	n/a
Equity (Book Value)	17.24M
Book Value Per Share	1.12
Working Capital	12.22M

Cash Flow

In the last 12 months, operating cash flow was 1.06 million and capital expenditures -57,002, giving a free cash flow of 1.00 million.

Operating Cash Flow	1.06M
Capital Expenditures	-57,002
Free Cash Flow	1.00M
FCF Per Share	n/a

Margins

Gross margin is 55.06%, with operating and profit margins of 13.44% and 24.80%.

Gross Margin	55.06%
Operating Margin	13.44%
Pretax Margin	13.78%
Profit Margin	24.80%
EBITDA Margin	15.15%
EBIT Margin	13.44%
FCF Margin	6.80%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.76%.

Dividend Per Share	0.03
Dividend Yield	0.76%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	14.42%
Buyback Yield	1.29%
Shareholder Yield	2.05%
Earnings Yield	5.10%
FCF Yield	1.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:6FK has an Altman Z-Score of 16.13 and a Piotroski F-Score of 5.

Altman Z-Score	16.13
Piotroski F-Score	5